PepTalk 2024 in San Diego
KACTUS will be exhibiting atĀ PepTalk San Diego at booth #217. Stop by our booth to...
Jan 04, 2024
Focusing on the Neuroendocrine Tumor Target SEZ6
Neuroendocrine neoplasms/tumors (NENs or NETs) are rare tumors that originate from specialized cells called neuroendocrine...
Jan 02, 2024
Butyrophilin (BTN) family: Ī³Ī“ T Cell Receptor Ligands, Immunomodulators and More
Immunotherapy is an essential option for current disease treatment. However, most patients fail to respond...
Dec 27, 2023
Webinar: Transforming Tumor Research: Engineering MHCs as Versatile Reagents
Speaker Dr. Manhee Suh, Co-founder & CTO, KACTUS What's Inside When dealing with solid tumors...
Dec 20, 2023
Empowering Gene Editing Therapy: The Atlas of Gene Editing Enzymes from KACTUS
Overview By leveraging its sophisticated āStructure Aided Design and Multiplex Screening (SAMSā¢)ā platform, along with...
Dec 05, 2023
AccuBaseā¢ Base Editor Enzyme: Globally In Stock Now
Overview AccuBaseā¢Ā is a new generation base editing tool independently developed by Base Therapeutics with exclusive...
Dec 01, 2023
AET 2023 in the US
WeĀ will be showcasing our products and services at the Antibody Engineering & Therapeutics (AET) event...
Nov 29, 2023